Coronavirus: British man sold phoney 'miracle cures' in US, authorities say
Trinity Covid-19 Sars Antipathogenic Treatment is not FDA approved
A British man has been charged with a federal crime after being accused of smuggling a phoney coronavirus cure into the US, prosecutors said.
Frank Richard Ludlow of West Sussex was charged in Los Angeles federal court with introducing misbranded drugs into interstate commerce and could face up to three years in prison if convicted, according to the US attorney's office.
Mr Ludlow is in custody after being arrested on drug charges in the UK last week.
Prosecutors alleged that Mr Ludlow, who is not a doctor, had been selling a concoction called “Trinity Remedy”, that he touted as a “miracle cure” for various ailments, to people in California and Utah via mail.
“This 'cure' - later rebranded as 'Trinity Mind, Body & Soul' - allegedly contained vitamin C, an enzyme mix, potassium thiocyanate, and hydrogen peroxide,” the US attorney's office statement said.
“Consumers were instructed to add 18 ounces of water, say a prayer, drink half of the solution, take a probiotic along with bee pollen, and then ingest the remainder of the solution.”
Authorities said Mr Ludlow sold between 300 and 400 of the treatment kits, but in February or March of this year as the coronavirus pandemic worsened, he began selling the kits under a new name: “Trinity Covid-19 Sars Antipathogenic Treatment.”
The treatments have not been approved by the US Food and Drug Administration for any medical use.
“Every major health authority has warned that there is no specific antiviral treatment for Covid-19 and no vaccine to prevent coronavirus infection,” according to the US attorney's office.
“Hucksters who hawk 'treatments' for this deadly disease put consumers' lives at risk by peddling unapproved drugs,” US attorney Nick Hanna said.
Associated Press
Subscribe to Independent Premium to bookmark this article
Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Premium subscription today.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies